drugset
Drugs / gp120 (A,B,C,A/E) Protein Vaccine
last change Dec 2023 re-read 2 minutes ago

gp120 (A,B,C,A/E) Protein Vaccine

Vaccine

Developed for
HIV infectious disease
Investigated by
Access to Advanced Health Institute (AAHI) · Brigham and Women's Hospital · Worcester HIV Vaccine

Trials 1 · a red edge is where a trial was stopped

today NCT04927585 · Ph 1
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04927585 Jul 2021 → Dec 2023 HIV infectious disease Worcester HIV Vaccine Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as gp120 (A,B,C,A/E) Protein Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT04927585 ↗
Modality Vaccine “gp120 (A,B,C,A/E) Protein Vaccine” NCT04927585 ↗
Route Intramuscular “Administered by intramuscular injection in the deltoid” NCT04927585 ↗